Suchergebnisse

A thorough bibliographic survey on the use of embryo-tests with aquatic animals for toxicity testing was performed. The data regarding to the compounds sensitivity (NOEC, LOEC, EC50 and LC50), the available resources for the different animal models (knowledge on the life-cycle, amenability for laboratory breeding, number of embryos produced and reproductive strategy, genomic and transcriptomic resources), together with the European pieces of legislation regarding to animal testing and the available testing guidelines of national and international agencies (OECD, EPA, ISO, ASTM, ICES) were gathered, aiming to the standardization of new embryo-test model species for toxicity testing of new and existing compounds. The data contained in this Data in Brief article is presented and discussed in the review article with the title Embryo bioassays with aquatic animals for toxicity testing and hazard assessment of emerging pollutants: a review [1]. The dataset is provided with this article as a supplementary file.

The hypothesis that exposure to certain environmental chemicals during early life stages may disrupt reproduction across multiple non-exposed generations has significant implications for understanding disease etiology and adverse outcomes. We demonstrate here reproductive multi and transgenerational effects, at environmentally relevant levels, of one of the most prescribed human pharmaceuticals, simvastatin, in a keystone species, the amphipod Gammarus locusta. The transgenerational findings has major implications for hazard and risk assessment of pharmaceuticals and other contaminants of emerging concern given that transgenerational effects of environmental chemicals are not addressed in current hazard and risk assessment schemes. Considering that the mevalonate synthesis, one of the key metabolic pathways targeted by simvastatin, is highly conserved among metazoans, these results may also shed light on the potential transgenerational effects of simvastatin on other animals, including humans. ; This research was funded by COMPETE 2020, Portugal 2020, the European Union through the ERDF and the Portuguese Foundation for Science and Technology – FCT (Transobesogen project – Trans-phyletic obesogenic responses: from epigenetic modules to transgenerational environmental impacts, reference: PTDC/CTA-AMB/31544/2017 – NORTE-01-0145-FEDER-031544). This research was also supported by the National Funds through FCT under the projects (UIDB/04423/2020; UIDP/04423/2020), by the Spanish Agencia Estatal de Investigación (CTM2017-84763-C3-2-R), and by the Galician Council of Culture, Education and Universities (ED431C2017/36), cofounded by ERDF. A PhD grant awarded to Susana Barros (PD/BD/143090/2018) was funded by the FCT ; SI

This is the accepted manuscript of the following article: Espíndola et al. Science of the Total Environment, 2019, 667, 197-207. https://doi.org/10.1016/j.scitotenv.2019.02.335 ; An innovative photoreactor, FluHelik, was used to promote the degradation of contaminants of emerging concern (CECs) by a photochemical UVC/H2O2 process. First, the system was optimized for the oxidation of a model antibiotic, oxytetracycline (OTC), using both ultrapure water (UPW) and a real urban wastewater (UWW) (collected after secondary treatment) as solution matrices. Following, the process was evaluated for the treatment of a UWW spiked with a mixture of OTC and 10 different pharmaceuticals established by the Swiss legislation at residual concentrations (∑CECs <660 μg L−1). The performance of the FluHelik reactor was analyzed both at lab and pre-pilot scale in multiple and single pass flow modes. The efficiency of the FluHelik photoreactor, at lab-scale, was evaluated at different operational conditions (H2O2 concentration, UVC lamp power (4, 6 and 11 W) and flow rate) and further compared with a conventional Jets photoreactor. Both photoreactors exhibited similar OTC removal efficiencies at the best conditions; however, the FluHelik reactor showed to be more efficient (1.3 times) in terms of mineralization when compared with the Jets reactor. Additionally, the efficiency of the UVC/H2O2 photochemical system using the FluHelik photoreactor in reducing the toxicity of the real effluent containing 11 pharmaceuticals was evaluated through zebrafish (Danio rerio) embryo toxicity bioassays. FluHelik scale-up from laboratory to pre-pilot to promote UVC/H2O2 photochemical process proved to be feasible ; This work was financially supported by: Associate Laboratory LSRE-LCM - UID/EQU/50020/2019 - funded by national funds through FCT/MCTES (PIDDAC). V.J.P. Vilar acknowledges the FCT Investigator 2013 Programme (IF/00273/2013). J.C.A. Espíndola acknowledges CNPq (Brazil) for his scholarship (205781/2014-4). R. Montes, R. Rodil and J.B. ...